Results 21 to 30 of about 13,097,347 (378)

Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India [PDF]

, 2011
Reports on treatment outcomes of visceral leishmaniasis (VL)-human immunodeficiency virus (HIV) coinfection in India are lacking. To our knowledge, none have studied the efficacy of liposomal amphotericin B in VL-HIV coinfection.
Alvar, Bachani, Berman, Bern, Bora, Braitstein, C. Ferreyra, D. Remartinez, G. Mitra, Hurissa, Ikomi, J. van Griensven, K. Pandey, L. Flevaud, Lin, Lyons, M. Pece, Mathur, N. Kumar, N. Verma, P. Das, P. K. Sinha, P. Kumar, P. P. Palma, Pintado, R. Kumar, R. Mahajan, Redhu, Sinha, Sinha, Sundar, Sundar, ter Horst, Thakur, van Griensven   +34 more
core   +2 more sources

Therapeutic Drug Monitoring of Amphotericin-B in Plasma and Peritoneal Fluid of Pediatric Patients after Liver Transplantation: A Case Series

Antibiotics, 2022
Fungal infections represent a serious complication during the post-liver transplantation period. Abdominal infections can occur following pre-existing colonization, surgical procedures, and permanence of abdominal tubes.
Francesca Tortora, Luigi Dei Giudici, Raffaele Simeoli, Fabrizio Chiusolo, Sara Cairoli, Paola Bernaschi, Roberto Bianchi, Sergio Giuseppe Picardo, Carlo Dionisi Vici, Bianca Maria Goffredo   +9 more
doaj   +1 more source

Liposomal amphotericin B—the future

Journal of Antimicrobial Chemotherapy, 2022
AbstractAdvances in medicine have led to a growing number of people with compromised or suppressed immune systems who are susceptible to invasive fungal infections. In particular, severe fungal infections are becoming increasingly common in ICUs, affecting people within and outside of traditional risk groups alike.
M Hoenigl, R Lewis, F L van de Veerdonk, P E Verweij, O A Cornely   +4 more
openaire   +7 more sources

Lipase-Responsive Amphotericin B Loaded PCL Nanoparticles for Antifungal Therapies

Nanomaterials, 2022
Amphotericin B is an antifungal drug used for the treatment of invasive fungal infections. However, its clinical use is limited due to its serious side effects, such as renal and cardiovascular toxicity.
Evelyn Osehontue Uroro, Richard Bright, Andrew Hayles, Krasimir Vasilev   +3 more
doaj   +1 more source

Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa [PDF]

, 2018
Background Cryptococcal meningitis accounts for more than 100,000 human immunodeficiency virus (HIV)–related deaths per year. We tested two treatment strategies that could be more sustainable in Africa than the standard of 2 weeks of amphotericin B ...
ACTA Trial Study Team, Adams, J, Bicanic, T, Bradley, J, Bright, P, Chan, AK, Chanda, D, Chawinga, C, Chen, T, Ellis, J, Gaskell, K, Harrison, TS, Heyderman, RS, Hosseinipour, MC, Jaffar, S, Kalata, N, Kanyama, C, Karunaharan, N, Kouanfack, C, Lakhi, S, Lalloo, DG, Lesikari, S, Lontsi, S, Lortholary, O, Loyse, A, Lupiya, D, Mapoure, YN, Mfinanaga, S, Molloy, SF, Mwaba, P, Ndong, J-G, Peirse, M, Sini, V, Stone, N, Temfack, E, van der Horst, C, van Oosterhout, JJ, Wang, D   +37 more
core   +4 more sources

Taming Amphotericin B [PDF]

Bioconjugate Chemistry, 2015
A strategy is introduced for enhancing the cellular selectivity of Amphotericin B (AmB) and other classes of membrane-disrupting agents. This strategy involves attaching the agent to a molecular umbrella to minimize the disruptive power of aggregated forms. Based on this approach, AmB has been coupled to a molecular umbrella derived from one spermidine
Vaclav Janout, Damien Thévenin, Yuming Yu, Wiley A. Schell, Steven L. Regen, John R. Perfect   +5 more
openaire   +2 more sources

Aspergillosis of the CNS in a pediatric liver transplant recipient: Case report and review [PDF]

, 1991
A 2-month-old infant who had undergone orthotopic liver transplantation at the age of 2 weeks for carbamoyl phosphate synthetase deficiency developed infection of the CNS due to Aspergillus fumigatus.
Green, M, Starzl, TE, Todo, S, Tzakis, A, Wald, ER   +4 more
core   +1 more source

Comparative efficacy and tolerability of amphotericin B lipid complex and liposomal amphotericin B in the treatment of invasive fungal infections in patients with hematological malignancies: literature review

Онкогематология, 2014
An overview of the literature data concerning the comparison of toxicity, efficacy and cost of amphotericin B lipid complex and liposomal amphotericin B, as well as their comparison with amphotericin B deoxycholate are provided.
N. V. Dmitrieva, I. N. Petukhova
doaj   +3 more sources

Drug-induced hypersensitivity syndrome by liposomal amphotericin-B: a case report [PDF]

, 2015
BACKGROUND: Liposomal amphotericin-B (Ambisome(®)) is widely used antifungal drug for treatments of invasive fungal infections. The use of liposomal amphotericin-B is increasing in medical setting because of its tolerability and potent antifungal ...
Hideo Kato, Hiroshige Mikamo, Jun Hirai, Katsuhiko Matsuura, Mao Hagihara, Yuka Yamagishi, Yukihiro Hamada, Yusuke Koizumi   +7 more
core   +1 more source

Itraconazole or Amphotericin B for Talaromycosis [PDF]

New England Journal of Medicine, 2017
Item does not contain ...
Bruggemann, R.J.M., Bruggemann, R.J.M., van de Veerdonk, F.L., Verweij, P.E.   +3 more
openaire   +6 more sources